• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    More On HIK.L

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Hikma Pharmaceuticals plc (HIK.L)

    -LSE
    2,032.00 Down 11.00(0.54%) Dec 19, 11:35AM EST
    Add to Portfolio
    ProfileGet Profile for:
    Hikma Pharmaceuticals plc
    13 Hanover Square
    London, W1S 1HW
    United Kingdom - Map
    Phone: 44 20 7399 2760
    Fax: 44 20 7399 2761
    Website: http://www.hikma.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drugs - Generic
    Full Time Employees:7,067

    Business Summary 

    Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms in the Middle East and North Africa, the United States, and Europe. It operates through three segments: Branded, Injectable, and Generic. The Branded segment offers 499 products in 1,256 dosage strengths and forms, which lie in the anti-infective, cardiovascular, central nervous system (CNS), and diabetes therapeutic areas. The Injectables segment markets 200 branded and non-branded products in 379 dosage strengths and forms with a focus on CNS, anti-infective, musculoskeletal, cardiovascular, and oncological therapeutic areas. This segment also offers sterile liquid, powder, lyophilized, and cytotoxic products. The Generics segment provides 11 products in 44 dosage strengths and forms for various therapeutic areas including analgesic, anti-infective, anti-inflammatory, cardiovascular, CNS, respiratory, hormonal, and others. This segment markets its products to chain stores, wholesalers, distributors, health systems, and governmental agencies in the form of tablets, capsules, solutions, and suspensions. In addition, the company offers anesthetics, anti-histamines, gastroenterology and metabolism, dermatology, genitourinary system, transplantation, vitamins and supplements, and miscellaneous products. Further, it manufactures plastic specialized medicinal sterile containers and API; and conducts bio-equivalency studies. The company was founded in 1978 and is based in London, the United Kingdom.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Hikma Pharmaceuticals plc

    Key Executives 
     PayExercised
    Mr. Said Samih Taleb Darwazah , 57
    Chairman and Chief Exec. Officer
    N/AN/A
    Mr. Mazen Samih Taleb Darwazeh , 56
    Exec. Vice Chairman, Chief Exec. Officer of MENA & Emerging Markets, Pres of MENA & Emerging Markets, Member of Nomination Committee and Member of Compliance, Responsibility & Ethics Committee
    N/AN/A
    Mr. Samih Darwazah , 83
    Founder and Honorary Life Pres
    N/AN/A
    Mr. Khalid Nabilsi ,
    Chief Financial Officer
    N/AN/A
    Dr. Ibrahim Jalal ,
    Sr. Corp. VP of Technical Affairs
    N/AN/A
    Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in GBp.